Mihail Obrocea
2023
In 2023, Mihail Obrocea earned a total compensation of $973K as Chief Medical Officer at MAIA Biotechnology, a 14% increase compared to previous year.
Compensation breakdown
| Option Awards | $499,416 |
|---|---|
| Salary | $359,945 |
| Other | $113,666 |
| Total | $973,027 |
Obrocea received $499.4K in option awards, accounting for 51% of the total pay in 2023.
Obrocea also received $359.9K in salary and $113.7K in other compensation.
Rankings
In 2023, Mihail Obrocea's compensation ranked 1,244th out of 2,978 executives tracked by ExecPay. In other words, Obrocea earned more than 58.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,244 out of 2,978 | 58th |
Division Manufacturing | 737 out of 1,637 | 55th |
Major group Chemicals And Allied Products | 493 out of 906 | 46th |
Industry group Drugs | 481 out of 869 | 45th |
Industry Pharmaceutical Preparations | 332 out of 627 | 47th |
Source: SEC filing on April 16, 2024.
Obrocea's colleagues
We found four more compensation records of executives who worked with Mihail Obrocea at MAIA Biotechnology in 2023.